Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1609561

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1609561

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Fusion Biopsy Market Growth & Trends:

The global fusion biopsy market size is expected to reach USD 1.2 billion by 2030, registering a CAGR of 8.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of prostate cancer, growing demand for targeted biopsy, and the rising utilization rate of multipara metric MRI in prostate cancer care are factors expected to drive the market during the forecast period. Moreover, factors such as rising awareness of the value of routine therapeutic interventions and emerging reimbursement policies are projected to drive demand in the market for fusion biopsy.

The high sensitivity and specificity of targeted fusion biopsy in delineating prostate lesions compared to other traditional technologies such as TRUS biopsy, PSA test, or Digital Rectal Examination is expected to contribute to the market growth. The reliability & reproducibility of the fusion biopsy system in the diagnosis of aggressive tumors is expected to make it a standard tool in prostate biopsy. An increasing number of radiologists gaining expertise in interpreting prostate MRI, coupled with the implementation of standard image grading systems such as PI-RADS and Gleason score, has increased the utilization rate of targeted MR/Ultrasound fusion biopsy systems.

The increasing number of government initiatives in terms of funding research, spreading awareness, and conducting mass screening programs related to prostate cancer are expected to play a crucial in the growth of the market. Some of the growth strategies adopted by market players include partnerships, product launches, participation in trade events and conferences, and acquisitions to drive and sustain growth in this highly competitive space.

Fusion Biopsy Market Report Highlights:

  • The transrectal segment held the largest market share in 2024, as it is the gold standard and commonly used method of prostate fusion biopsy
  • The transperineal segment is expected to grow at the fastest rate during the forecast period owing to the safety, diagnostic efficiency, and ability to access ventral prostate areas
  • The hospital segment accounted for the largest revenue share in 2024, owing to factors such as the increasing procurement rate of MR/US targeted fusion biopsy systems in teaching hospitals
  • The diagnostics centers segment is expected to expand at a significant rate over the forecast period. Shorter wait times, cost efficiency, and developing reimbursement paradigm are the factors expected to drive the growth of this segment
  • North America held the largest market share in 2024 and is anticipated to maintain its dominance over the forecast period
Show more
Product Code: GVR-4-68038-844-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Biopsy route
    • 1.1.2. End-use
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for Primary Interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for Primary Interviews in Latin America
      • 1.3.5.5. Data for Primary Interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Biopsy route outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Fusion Biopsy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing prevalence of prostate cancer
      • 3.4.1.2. Technological advancements in fusion imaging modalities
      • 3.4.1.3. Increasing funds and investments by public and private sector
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. High cost of fusion biopsy system
      • 3.4.2.2. Liquid biopsy system
  • 3.5. Fusion Biopsy Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic Landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies
    • 3.5.5. Covid-19 Impact Analysis

Chapter 4. Fusion Biopsy Market: Biopsy Route Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Transrectal
    • 4.1.2. Transperineal
  • 4.2. Biopsy Route Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Fusion Biopsy Market by Biopsy Route Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Transrectal
      • 4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 4.5.2. Transperineal
      • 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Fusion Biopsy Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospitals
    • 5.1.2. Diagnostic centers
    • 5.1.3. Ambulatory care centers
  • 5.2. End-use, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Fusion Biopsy Market by End-use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospitals
      • 5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Diagnostic centers
      • 5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. Ambulatory care centers
      • 5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Fusion Biopsy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2024
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. SWOT Analysis by Factor (Political & Legal, Economic and Technological)
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East and Africa
  • 6.6. Market Size, & Forecasts and Trend Analysis, 2022 to 2030:
  • 6.7. North America
    • 6.7.1. U.S.
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.1.3. Competitive Landscape
      • 6.7.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Canada
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.2.3. Competitive Landscape
      • 6.7.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. Mexico
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.3.3. Competitive Landscape
      • 6.7.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.8. Europe
    • 6.8.1. UK
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.1.3. Competitive Landscape
      • 6.8.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.2. Germany
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.2.3. Competitive Landscape
      • 6.8.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.3. France
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.3.3. Competitive Landscape
      • 6.8.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.4. Italy
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.4.3. Competitive Landscape
      • 6.8.4.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.5. Spain
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.5.3. Competitive Landscape
      • 6.8.5.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.6. Denmark
      • 6.8.6.1. Key Country Dynamics
      • 6.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.6.3. Competitive Landscape
      • 6.8.6.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.7. Sweden
      • 6.8.7.1. Key Country Dynamics
      • 6.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.7.3. Competitive Landscape
      • 6.8.7.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.8.8. Norway
      • 6.8.8.1. Key Country Dynamics
      • 6.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.8.3. Competitive Landscape
      • 6.8.8.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Japan
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Regulatory Landscape/Reimbursement Scenario
      • 6.9.1.3. Competitive Landscape
      • 6.9.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.2. China
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.9.2.3. Competitive Landscape
      • 6.9.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.3. India
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.9.3.3. Competitive Landscape
      • 6.9.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.4. South Korea
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.9.4.3. Competitive Landscape
      • 6.9.4.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.5. Thailand
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.9.5.3. Competitive Landscape
      • 6.9.5.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.9.6. Australia
      • 6.9.6.1. Key Country Dynamics
      • 6.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.9.6.3. Competitive Landscape
      • 6.9.6.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.10. Latin America
    • 6.10.1. Brazil
      • 6.10.1.1. Key Country Dynamics
      • 6.10.1.2. Regulatory Landscape/Reimbursement Scenario
      • 6.10.1.3. Competitive Landscape
      • 6.10.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.10.2. Argentina
      • 6.10.2.1. Key Country Dynamics
      • 6.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.10.2.3. Competitive Landscape
      • 6.10.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.11. MEA
    • 6.11.1. South Africa
      • 6.11.1.1. Key Country Dynamics
      • 6.11.1.2. Regulatory Landscape/Reimbursement Scenario
      • 6.11.1.3. Competitive Landscape
      • 6.11.1.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.11.2. Saudi Arabia
      • 6.11.2.1. Key Country Dynamics
      • 6.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.11.2.3. Competitive Landscape
      • 6.11.2.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.11.3. UAE
      • 6.11.3.1. Key Country Dynamics
      • 6.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.11.3.3. Competitive Landscape
      • 6.11.3.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.11.4. Kuwait
      • 6.11.4.1. Key Country Dynamics
      • 6.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.11.4.3. Competitive Landscape
      • 6.11.4.4. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competitive Categorization
    • 7.2.1. Innovators
    • 7.2.2. Market leaders
    • 7.2.3. Emerging players
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2024
  • 7.4. Public Companies
    • 7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 7.4.2. Company market share/ranking, by region
    • 7.4.3. Competitive dashboard analysis
      • 7.4.3.1. Market differentiators
      • 7.4.3.2. Synergy analysis: major deals and strategic alliances
  • 7.5. Private Companies
    • 7.5.1. List of key emerging companies/technology disruptors/innovators
    • 7.5.2. Funding outlook
    • 7.5.3. Regional network map
    • 7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
    • 7.5.5. Supplier ranking
    • 7.5.6. Key company profiled
    • 7.5.7. Eigen
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Koninklijke Philips N.V.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Hitachi, Ltd.
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. MedCom
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. ESAOTE SPA
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Product benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. KOELIS
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Product benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. Focal Healthcare
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Product benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. GeoScan Medical
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Product benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. UC-Care Medical Systems Ltd.
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Product benchmarking
      • 7.5.15.4. Strategic initiatives
Show more
Product Code: GVR-4-68038-844-2

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 4 North America fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 6 U.S. fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 8 Canada fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 11 Europe fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.K. fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 13 U.K. fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Germany fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 15 Germany fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Italy fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 17 Italy fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 France fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 19 France fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 21 Spain fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 23 Denmark fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 25 Sweden fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Japan fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 32 Japan fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 India fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 34 India fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 China fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 36 China fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Thailand fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 38 Thailand fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 40 South Korea fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 42 Australia fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 45 Latin America fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 47 Brazil fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 49 Mexico fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 51 Argentina fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA fusion biopsy market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 54 MEA fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 56 South Africa fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE fusion biopsy market, by biopsy route, 2018 - 2030 (USD Million)
  • Table 60 UAE fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait fusion biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait fusion biopsy market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary Interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Fusion biopsy market: market outlook
  • Fig. 14 Fusion biopsy market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Fusion biopsy market driver impact
  • Fig. 20 Fusion biopsy market restraint impact
  • Fig. 21 Fusion biopsy market strategic initiatives analysis
  • Fig. 22 Fusion biopsy market: biopsy route movement analysis
  • Fig. 23 Fusion biopsy market: biopsy route outlook and key takeaways
  • Fig. 24 Transrectal market estimates and forecast, 2018 - 2030
  • Fig. 25 Transperineal market estimates and forecast, 2018 - 2030
  • Fig. 26 Fusion biopsy market: end-use movement analysis
  • Fig. 27 Fusion biopsy market: end-use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 29 Diagnostic centers market estimates and forecast, 2018 - 2030
  • Fig. 30 Ambulatory care centers market estimates and forecast, 2018 - 2030
  • Fig. 31 Fusion biopsy market: Regional movement analysis
  • Fig. 32 Fusion biopsy market: regional outlook and key takeaways
  • Fig. 33 Fusion biopsy market share and leading players
  • Fig. 34 North America market share and leading players
  • Fig. 35 Europe market share and leading players
  • Fig. 36 Asia Pacific market share and leading players
  • Fig. 37 Latin America market share and leading players
  • Fig. 38 Middle East & Africa market share and leading players
  • Fig. 39 North America: SWOT
  • Fig. 40 Europe SWOT
  • Fig. 41 Asia Pacific SWOT
  • Fig. 42 Latin America SWOT
  • Fig. 43 MEA SWOT
  • Fig. 44 North America, by country
  • Fig. 45 North America
  • Fig. 46 North America market estimates and forecast, 2018 - 2030
  • Fig. 47 U.S.
  • Fig. 48 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 49 Canada
  • Fig. 50 Canada market estimates and forecast, 2018 - 2030
  • Fig. 51 Europe
  • Fig. 52 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 53 UK
  • Fig. 54 UK market estimates and forecast, 2018 - 2030
  • Fig. 55 Germany
  • Fig. 56 Germany market estimates and forecast, 2018 - 2030
  • Fig. 57 France
  • Fig. 58 France market estimates and forecast, 2018 - 2030
  • Fig. 59 Italy
  • Fig. 60 Italy market estimates and forecast, 2018 - 2030
  • Fig. 61 Spain
  • Fig. 62 Spain market estimates and forecast, 2018 - 2030
  • Fig. 63 Switzerland
  • Fig. 64 Switzerland market estimates and forecast, 2018 - 2030
  • Fig. 65 Belgium
  • Fig. 66 Belgium market estimates and forecast, 2018 - 2030
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 69 China
  • Fig. 70 China market estimates and forecast, 2018 - 2030
  • Fig. 71 Japan
  • Fig. 72 Japan market estimates and forecast, 2018 - 2030
  • Fig. 73 India
  • Fig. 74 India market estimates and forecast, 2018 - 2030
  • Fig. 75 Thailand
  • Fig. 76 Thailand. market estimates and forecast, 2018 - 2030
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 79 Australia
  • Fig. 80 Australia. market estimates and forecast, 2018 - 2030
  • Fig. 81 Latin America
  • Fig. 82 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 83 Brazil
  • Fig. 84 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 85 Mexico
  • Fig. 86 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 87 Argentina
  • Fig. 88 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 89 Middle East and Africa
  • Fig. 90 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 95 UAE
  • Fig. 96 UAE market estimates and forecast, 2018 - 2030
  • Fig. 97 Participant categorization- fusion biopsy market
  • Fig. 98 Market share of key market players- fusion biopsy market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!